open access

Vol 14, No 5 (2019)
Original Papers
Published online: 2019-10-31
Get Citation

Pacemaker and transurethral procedures of prostate and bladder tumors. Experiences of the Department of Urology, Medical University of Warsaw

Elżbieta Borowiecka, Lidia Ida Jureczko, Tomasz Borkowski, Piotr Kuzaka, Bolesław Kuzaka, Piotr Radziszewski
DOI: 10.5603//FC.2019.0100
·
Folia Cardiologica 2019;14(5):439-444.

open access

Vol 14, No 5 (2019)
Original Papers
Published online: 2019-10-31

Abstract

We have the analyzed the course of surgery in 146 patients with pacemakers who underwent transurethral resection op prostate (TURP) or bladder tumor (TURBT) at The Depatrment or Urology in 2014-2018. In the study group, spinal anesthesia was performed in 48 patients (32.9%) and general in 98 patients (67.1%). The average time of surgery was 71.8 minutes. Bipolar electroresections were performed in 6 patients and monopolar in 140 patients. ECG monitoring and pulse oximetry evaluation were used continuously and up to 4 hours after the procedure, resting 12-lead ECG was performed before and immediately after surgery. Pacemaker control was performed before and after the procedure in the pacemaker control office. There was no case of significant cardiac pacemaker disturbances observed. Transurethral electroresection of bladder and prostate tumors in patients with implanted pacemakers while following guidelines and recommendations were not associated with the occurrence of pacemaker complications.

Abstract

We have the analyzed the course of surgery in 146 patients with pacemakers who underwent transurethral resection op prostate (TURP) or bladder tumor (TURBT) at The Depatrment or Urology in 2014-2018. In the study group, spinal anesthesia was performed in 48 patients (32.9%) and general in 98 patients (67.1%). The average time of surgery was 71.8 minutes. Bipolar electroresections were performed in 6 patients and monopolar in 140 patients. ECG monitoring and pulse oximetry evaluation were used continuously and up to 4 hours after the procedure, resting 12-lead ECG was performed before and immediately after surgery. Pacemaker control was performed before and after the procedure in the pacemaker control office. There was no case of significant cardiac pacemaker disturbances observed. Transurethral electroresection of bladder and prostate tumors in patients with implanted pacemakers while following guidelines and recommendations were not associated with the occurrence of pacemaker complications.

Get Citation

Keywords

pacemaker; transurethral procedures; TURP; TURBT

About this article
Title

Pacemaker and transurethral procedures of prostate and bladder tumors. Experiences of the Department of Urology, Medical University of Warsaw

Journal

Folia Cardiologica

Issue

Vol 14, No 5 (2019)

Pages

439-444

Published online

2019-10-31

DOI

10.5603//FC.2019.0100

Bibliographic record

Folia Cardiologica 2019;14(5):439-444.

Keywords

pacemaker
transurethral procedures
TURP
TURBT

Authors

Elżbieta Borowiecka
Lidia Ida Jureczko
Tomasz Borkowski
Piotr Kuzaka
Bolesław Kuzaka
Piotr Radziszewski

References (23)
  1. Ackermann R, Frohmüller H. [Transurethral resection in patients with cardiac pacemakers (author's transl)]. Urologe A. 1976; 15(4): 185–187.
  2. Fein RL. Transurethral electrocautery procedures in patients with cardiac pacemakers. JAMA. 1967; 202(1): 101–103.
  3. Greber F, Frick J, Marberger H. [Transurethral electrosurgery of the prostate in patients with intracardiac pacemakers]. Urol Int. 1970; 25(5): 540–550.
  4. Greene LF, Myers GH, McCallister BD. Transurethral resection of the prostate in patients with cardiac pacemakers. Br J Urol. 1969; 41(5): 572–578.
  5. Lichter I, Borrie J, Miller WM. Radio-frequency hazards with cardiac pacemakers. Br Med J. 1965; 1(5449): 1513–1518.
  6. Sowton E, Gray K, Preston T. Electrical interference in non-competitive pacemakers. Br Heart J. 1970; 32(5): 626–632.
  7. Wajszczuk WJ, Mowry FM, Dugan NL. Deactivation of a demand pacemaker by transurethral electrocautery. N Engl J Med. 1969; 280(1): 34–35.
  8. Beinart R, Nazarian S. Effects of external electrical and magnetic fields on pacemakers and defibrillators: from engineering principles to clinical practice. Circulation. 2013; 128(25): 2799–2809.
  9. Burchell HB. Hidden hazards of cardiac pacemakers. Circulation. 1961; 24: 161–163.
  10. Wilkoff BL, Auricchio A, Brugada J, et al. Heart Rhythm Society, European Heart Rhythm Association, American College of Cardiology, American Heart Association, European Society of Cardiology, Heart Failure Association of ESC, Heart Failure Society of America, Heart Rhythm Society (HRS), European Heart Rhythm Association (EHRA), American College of Cardiology (ACC), American Heart Association (AHA), European Society of Cardiology (ESC), Heart Failure Association of ESC (HFA), Heart Failure Society of America (HFSA). HRS/EHRA Expert Consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association. Europace. 2008; 10(6): 707–725.
  11. Partin AW, Wein AJ, Kavoussi LR. et al. Campbell-Walsh urology e-book: 4-volume set. Elsevier Health Sciences, Milton 2015.
  12. Schutz W. [Transurethral electro-resection in patients with cardiac pacemakers (author's transl)]. Urologe A. 1979; 18(5): 247–249.
  13. Mangar D, Atlas GM, Kane PB. Electrocautery-induced pacemaker malfunction during surgery. Can J Anaesth. 1991; 38(5): 616–618.
  14. Pili-Floury S, Farah E, Samain E, et al. Perioperative outcome of pacemaker patients undergoing non-cardiac surgery. Eur J Anaesthesiol. 2008; 25(6): 514–516.
  15. Kakouros N, Kakouros SN. Pacemaker malfunction risks within the electromagnetically rich hospital environment. Hellenic J Cardiol. 2018; 59(4): 247–248.
  16. Lee D, Sharp VJ, Konety BR. Use of bipolar power source for transurethral resection of bladder tumor in patient with implanted pacemaker. Urology. 2005; 66(1): 194.
  17. Chakravarthy M, Prabhakumar D, George A. Anaesthetic consideration in patients with cardiac implantable electronic devices scheduled for surgery. Indian J Anaesth. 2017; 61(9): 736–743.
  18. Crossley GH, Poole J, Rozner M, et al. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the Perioperative Management of Patients with Implantable Defibrillators, Pacemakers and Arrhythmia Monitors: Facilities and Patient Management. Heart Rhythm. 2011; 8(7): 1114–1154.
  19. Hatch PD. Surgical and anaesthetic considerations in transurethral resection of the prostate. Anaesth Intensive Care. 1987; 15(2): 203–211.
  20. Jain A, Jain K, Bhagat H, et al. Anesthetic management of a patient with hypertrophic obstructive cardiomyopathy with dual-chamber pacemaker undergoing transurethral resection of the prostate. Ann Card Anaesth. 2010; 13(3): 246–248.
  21. Flachenecker G, Fastenmeier K. High frequency current effects during transurethral resection. J Urol. 1979; 122(3): 336–341.
  22. Gauss A, Hübner C, Meierhenrich R, et al. Perioperative risk of bradyarrhythmias in patients with asymptomatic chronic bifascicular block or left bundle branch block: does an additional first-degree atrioventricular block make any difference? Anesthesiology. 1998; 88(3): 679–687.
  23. Godin JF, Petitot JC. STIMAREC report. Pacemaker failures due to electrocautery and external electric shock. Pacing Clin Electrophysiol. 1989; 12(6): 1011.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl